Immuneering Corporation (IMRX) Total assets 2020–2023
Immuneering Corporation (IMRX) total assets at each fiscal year-end, per SEC filings.
$102.6MFY2023 · since FY2020: $38.4M → $102.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $102.6M | -16.2% |
| FY2022 | $122.4M | -26.6% |
| FY2021 | $166.7M | +333.9% |
| FY2020 | $38.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMRX financial trends
IMRX RevenueIMRX Net incomeIMRX Net marginIMRX Gross profitIMRX Gross marginIMRX Operating incomeIMRX Operating marginIMRX Operating cash flowIMRX Free cash flowIMRX Capital expendituresIMRX Return on equityIMRX Stock buybacksIMRX Dividends paidIMRX Total liabilitiesIMRX Shareholders’ equityIMRX overview →